[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ANAB":3,"homepage-market-summary":30,"stock-news-ANAB":173},{"ticker":4,"date":5,"profile":6,"quote":14},"ANAB","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"AnaptysBio, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).","104","San Diego, CA",{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},48.53,48.97,49.83,48.28,48.63,-0.1,-0.21,440958.434847,9448,48.7548,89.33334,6.66667,566220.0025472459,50.6,2435,{"status":31,"indices":32,"watchlist":77,"sectors":99,"benchmarks":155},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":75,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,false,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":39,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":39,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":39,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":39},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":39},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":75},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":39},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":39},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":39},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},18,[176,182,188,194,200,206,212,217,222,228,233,238,243,248,252,257,262,267],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"AnaptysBio (NASDAQ:ANAB) Stock Bumped Up to Buy by Wall Street Zen - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxQMzEyN0N6bHh6cm5iRnpybmlEdTIySzRZcE83M1RYN1pUcXZIV3RUY1hxcjNqaDBsZThyTkZmNW95S28yT2pWQzBVdXBFdGV2ekhnWnZFcE96enhfWU1rZjlsdU1pZmI0djQ3ZF9UWGRFbnp6WmJVWnNHREJ3OUpKcFN0cE8yRFpWU21veDlBR0oxV01KWXJxUGw5MDZ4MWZwY1FJNDlFQVNNcjBYUUs2R19ua3BMN0Vfa2MwSlN2a1M0YU4w?oc=5","Sat, 26 Sep 2026 05:14:46 GMT","AnaptysBio (NASDAQ:ANAB) Stock Bumped Up to Buy by Wall Street Zen MarketBeat","MarketBeat",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxNX3h0QUpVN0dHVzFROHZxLXp2NFU5VVhiVEE4N0ZQNnhqcHowZHFjMTRPb0FCbTFlQ1lqZkgzTzRfemg1Wk1zMEQyNE9WS1E0RVg5WjZqc3lraVV6SHd6SGx3cHFjNzREWXpHNWNUN0RzaGJkdlBSdzVkWk1YNWpWaXU0bEN0d3RSVTUxUFR1dWY5MUNHYmJvc2NiWQ?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates Yahoo Finance","Yahoo Finance",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Director Hollings C. Renton plans to sell 5,000 AnaptysBio (ANAB) shares valued at about $249K. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxPSTdYV2pReHhJcThxbXA4a0pSQ2g5N01WTXUtWWNuSTRhSU5nalF0Q0REbXRDVDN4bF9taTdfam9GNDE5WnlPMXRsZFNNVlRUWjBZdXVOY3JPc05DUk96Z1dibG5LYmdBWmtmMmpwdHhOSVZzTFVtb3ZjYkF1ZlFDbVpvZUxxRDJsaEdYLUJ2R1BKZ1pyakE?oc=5","Thu, 01 Oct 2026 20:08:21 GMT","Director Hollings C. Renton plans to sell 5,000 AnaptysBio (ANAB) shares valued at about $249K. Stock Titan","Stock Titan",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"How Return To Profit Will Impact AnaptysBio (ANAB) Investors - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 25 Sep 2026 16:32:50 GMT","How Return To Profit Will Impact AnaptysBio (ANAB) Investors Simply Wall Street","Simply Wall Street",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxNNEJ5cC1sUlQwWDZLQUtLZ002WTRKbjhlNzJNLXo5SjNhQXd0dlVVTWk0MG13dXg3bEVDc0QtZXBsOENwMldtTjFKVmxTVEQyN29QTFkyLU5yNlhPNm9ZbFhOTVBEVlVsMzdGbHdMajBjYzFUdXYybnR4aUNtd3BFMXlXTGh3eHpnQ3ppaG16N2p5SjhYaGVrVXpiR1U?oc=5","Wed, 30 Sep 2026 19:05:01 GMT","ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00 GuruFocus","GuruFocus",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgJBVV95cUxNQlBzRHJPaXAtSzM4QUFsTDJTSDNRbDhmRDdvVmNJalp1dUFaZ3preXNnWDdzUW1ldXhxUXFEbHBIT3dseEJQeHRKeFhOLUR1M2pZSl9WcVVpM3VSa3ZtVXZWYXh4SGdQelpfWXdEdFlhckJKS2JsYzRuLXpvOExrLVMydWNXb2dyOXRWbE1kVHVheGVfWTNvWFdUMnFLX2VNMm9Za3RQZWVoWnpWWGQxcE4xXzFOYVFfWWt6X2pDX1BQNHZaeFJOaEhuM0JsYUFmVzFENDlhVTZNbUVJSGtNTHZSWXdpOWNsLWJrZlJwM3FUbkxUN0NFbHVpaEM5a0VxVktndXp6RDVDd3VmaVdYNUx1bVVwS2prN0NMSjU1WEVjaWIzN19yVFBB?oc=5","Thu, 24 Sep 2026 09:12:00 GMT","Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX) The Globe and Mail","The Globe and Mail",{"title":213,"link":214,"pubDate":215,"description":216,"source":187},"AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikwFBVV95cUxPR01selVkZ3d3ZWxFQzNZUmZWeVhxcGE3RzBCOFB2VnhMWGFjelBXamhIY2hpN0s3NFlpSWZDZmJqN2tlc3JaTGJtR0hTejI5bnJkRXhmNUtXby1XbnIwRy03a3lrdmRCanhnTU5faWt5QWUxZUZod29BdjV1QmJaeWM0MXZoR00zVWx5SmNLcHkwQWs?oc=5","Sat, 26 Sep 2026 14:11:13 GMT","AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance Yahoo Finance",{"title":218,"link":219,"pubDate":220,"description":221,"source":193},"After an $18.03-per-share option exercise, AnaptysBio (ANAB) director sells 5,000 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxPdXJCTHNndFRoZzNOQnRNY3JRaG5RS1liemphOWlSX1Z6akt2LWJvVHJzSnFZREtUQkFiV1RveG9CTk9VSl9zZXh6b3lIb05fNURZMm1UME5tMTlwcHQwV3BXdmJJWTY5dWFzQXZvclc1bHVXYXA4VkNOMmR1WXV4OVU3SHliUVN2MkxZUGNVcXdqdTV2UXE5UjNONEQwQ0FWaV83YVpXRDA4aHhl?oc=5","Fri, 02 Oct 2026 21:48:15 GMT","After an $18.03-per-share option exercise, AnaptysBio (ANAB) director sells 5,000 shares. Stock Titan",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"Leerink Partners maintains Outperform rating on AnaptysBio, $81 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxNYkduY29Qa1lYcFhnWDM0ZUtNZzZYZENaeWNERU9MdzA3M2JSNFF0OXczYmVhMXNBQkFycmxhaGJ0b1pXQ0JNQmVRNU1UanJCUjVfbEZtU1pGX2JzYko1MEUzWUNyWkxZUHV4NFJjUF9nWXJPemMxV1RDU2VTUVJjcGNKR3VHNTA0ODFDcU4yQjlmbmVXNzZwT09OU2ZYTXMzMXplMzhHdWJFTTBvVk10cDFXVGdRdkJjclFmbzhLdHhubmtRd1ZWZ29ueG9qMkZrMlE?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Leerink Partners maintains Outperform rating on AnaptysBio, $81 price target TradingView","TradingView",{"title":229,"link":230,"pubDate":231,"description":232,"source":199},"Is AnaptysBio (ANAB) Cheap On Its Royalty Story Despite Tax Driven Earnings? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sun, 27 Sep 2026 01:55:14 GMT","Is AnaptysBio (ANAB) Cheap On Its Royalty Story Despite Tax Driven Earnings? Simply Wall Street",{"title":234,"link":235,"pubDate":236,"description":237,"source":181},"Leerink Partners Issues Pessimistic Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3gFBVV95cUxPdnlDLVctV1MzUHVZRWVjZm5GeDBqR3pxaXpkN1dJNzhxMmlaODZkaUJqdzM2V1A0VWtWWVF2Z2x2S3ZxV0NzZVlreXV6cE4yMUE3cjkyTkJQQ0NpNmNXaXdrZHM3Smx3cWp2RFhfaDg3ejMySzZQYTI5ZVZVOWpfWEtBQUk4VmVOamVRdEd4YXI5LWJ0MkEwNjJzMHpmRGF3OVpLajJ2dGtMcUZXQ0tBMjJ3SnJsTGFhTFJyY3E5N0NwQXRSeHpfTGw0RFhlVS1qTkRfU0kyWllvY3RlU2c?oc=5","Wed, 23 Sep 2026 13:27:31 GMT","Leerink Partners Issues Pessimistic Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price MarketBeat",{"title":239,"link":240,"pubDate":241,"description":242,"source":187},"AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxNYTNtWUxOWVdOcVZHdXdGa0tOek92T2pEQlZiSkp4RGlrZU1uM2pPQ1Q5Ym1xMWVnVVRUcEwyelRMdGNRNXJUU2wtSURIU0VtamRrWHNQU2NCZVR5MjdCX2JRU1ZEcW9RdmJRa1JoTXJjWGg1RFYyRHUtODVTR3hTYlRtUTVfSDZJOUhWVS04S01uM1djbEdlOXpkOUVxSEtN?oc=5","Sat, 26 Sep 2026 03:38:00 GMT","AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns? Yahoo Finance",{"title":244,"link":245,"pubDate":246,"description":247,"source":181},"JPMorgan Chase & Co. Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $60.00 - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxPbHZPTjl4elluWW5lblFMM2dXNEtSM2ptUmhoRFVHN0pnZ1kxZzhkRXRNRFN6Q2doRDJsV0VRejFaalVsVEk5WWUtZ2k4UGNwYzN6ZFB2ck5BN20yYVAxZmFXc0lUWjU3VHc1VzkxancyU1JfZkhRWGRIbV9SSFVPaTJsaWxDbkY1eW9rTEpwZzdsVUl3RFBEVGNJZWZXbTJGbFppOHJrNU02NnJraURIOGlaeEZ3SWcxeWNadnJZQTEtYTNpZmNJ?oc=5","Wed, 30 Sep 2026 18:31:55 GMT","JPMorgan Chase & Co. Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $60.00 MarketBeat",{"title":249,"link":250,"pubDate":185,"description":251,"source":187},"AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxOWWt1ZnU2Q3A2cl9vZlZJNTNXel9vRUN5RHhNUzY3X0h1ZEtQRnNGU3lzS1plbUdlZTdVbmY4R21LZXVzVHN4OTBOcFBic3lpeE1KcG5wQmt5V2xWRklObGt2Tm1lN2hPY0NLWDhEbmNjWGF3U2JXdF82S1A4dFRrNkZ6NV9KTERITG9NLTdXOENQRVFWaHhKNVNzNHpZNGVfT0E?oc=5","AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours Yahoo Finance",{"title":253,"link":254,"pubDate":255,"description":256,"source":181},"AnaptysBio (NASDAQ:ANAB) Shares Down 6.2% - What's Next? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxPQ1V4b3FLWTBzd3kyVE1yNnpGemN3SDlFSUU1VWYwM2tmRzZGTnR4eVRnMGdFZ0dhcDU1YXhmdWlYZEx5ZDJpSzA2QVhRS3luNDJ1ek1MWEpZMjdhNDJoUHJ0TGx0WFRYTk1OS0ZxaURDZnZOMm1PYTV6dGpDR240SmFueTRPQnRoMDlQc3VrOVpJRzZrZWdacmlGUWFzangzYW14Z1piSFJKUHBu?oc=5","Tue, 22 Sep 2026 17:06:56 GMT","AnaptysBio (NASDAQ:ANAB) Shares Down 6.2% - What's Next? MarketBeat",{"title":258,"link":259,"pubDate":260,"description":261,"source":181},"Q3 Earnings Estimate for AnaptysBio Issued By HC Wainwright - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxNNFBNMnhHaE53UmhtN0N2LUxQZWdNOHVxUGJIRUhHU0VtYVp6UWNHd2piX3ZpNlFTcWRFU0ZRMjdIUTdTcnNCUVh2UkxmRXFDWWxudnBfRG9kb2ZqbDVCc0dsNF80cUZtcHV3RlpieXk2eXVHWVA5TzdiU0RKZGlGaENjdjY5NnR4Rl9jMGkzUzl6ZGRsaUtRVmc2OTU1UF9SSUd3eWRmTHJmYmVLOVJUNWpzemRtUk01bWlZaGw2djk?oc=5","Thu, 24 Sep 2026 10:46:24 GMT","Q3 Earnings Estimate for AnaptysBio Issued By HC Wainwright MarketBeat",{"title":263,"link":264,"pubDate":265,"description":266,"source":181},"AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of \"Moderate Buy\" by Analysts - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4AFBVV95cUxOMWRKV01qWU5ub0h3YUtrSzNjRTlWOFpGelI1MmRKY2h0ZWJ6ajYxNS1fNDZ1NFFDSW50N1E0NUs5bl9WQm4tMDZaRnE0S3FOdV9jRXktdGlQa0pqOFF6ZEx3aVZhRnZzWndQNWI2bjJjNjBFcDliVmprUEVGVkNEQ1FTNHlFU2pabVZHTGJWbWhPRzJKUVFUZzZqYThpNExXM2d5V09hdEVIZ2lXazY2d1dvMDVUcjRZaGFJekVpQzRCOXR4NjBSVmM1Tzl5N3piN19Ca2tSeXMwdHJJaU5fUg?oc=5","Wed, 23 Sep 2026 06:33:20 GMT","AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of \"Moderate Buy\" by Analysts MarketBeat",{"title":268,"link":269,"pubDate":270,"description":271,"source":181},"Bank of America Corp DE Makes New $28.20 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxNZHdESFpBWG1UZkhqRmUzd1VCcndUdEM4Mm5aWDZGdVpuWVlsVk5TZnZ4NjhwVWJhWXYwTWFFRGx0cFRRdXF4U253SXJsQXVjdmF0SmxpMTFQelEtYkFzdWh0TTZmbm1EWXAzRlRNVDU5WmhPQWtiYkhZS0xrM0hwRmJhRlNnUTRYb1pXUHJ4eGRYNER6Zk4wNE5SVDFFVDMwUHZCMG1KbG95U2ZSdHJJaTJqdzZiN0JLUlhneHQwNm5EQkdhY18yQTF2QXFkeUFfWGk4QzE5dTg?oc=5","Wed, 23 Sep 2026 07:19:38 GMT","Bank of America Corp DE Makes New $28.20 Million Investment in AnaptysBio, Inc. $ANAB MarketBeat"]